AR083769A1 - Formulaciones orales que comprenden polietilenglicol - Google Patents

Formulaciones orales que comprenden polietilenglicol

Info

Publication number
AR083769A1
AR083769A1 ARP110104128A ARP110104128A AR083769A1 AR 083769 A1 AR083769 A1 AR 083769A1 AR P110104128 A ARP110104128 A AR P110104128A AR P110104128 A ARP110104128 A AR P110104128A AR 083769 A1 AR083769 A1 AR 083769A1
Authority
AR
Argentina
Prior art keywords
polyethylene glycol
include polyethylene
oral formulations
solid
formulation
Prior art date
Application number
ARP110104128A
Other languages
English (en)
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1018647.6A external-priority patent/GB201018647D0/en
Priority claimed from GBGB1104049.0A external-priority patent/GB201104049D0/en
Priority claimed from GBGB1107626.2A external-priority patent/GB201107626D0/en
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of AR083769A1 publication Critical patent/AR083769A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Abstract

Una formulación sólida para administración oral como un sólido que comprende polietilenglicol y un sólido adicional tal como manitol. La formulación puede usarse para prevenir trastornos gastrointestinales tales como constipación en sujetos sanos. En algunas realizaciones, la formulación sólida es para masticar o para chupar.
ARP110104128A 2010-11-04 2011-11-04 Formulaciones orales que comprenden polietilenglicol AR083769A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1018647.6A GB201018647D0 (en) 2010-11-04 2010-11-04 Formulations
US41210910P 2010-11-10 2010-11-10
GBGB1104049.0A GB201104049D0 (en) 2011-03-09 2011-03-09 Formulations
GBGB1107626.2A GB201107626D0 (en) 2011-05-06 2011-05-06 Formulations

Publications (1)

Publication Number Publication Date
AR083769A1 true AR083769A1 (es) 2013-03-20

Family

ID=44999794

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110104128A AR083769A1 (es) 2010-11-04 2011-11-04 Formulaciones orales que comprenden polietilenglicol

Country Status (20)

Country Link
US (3) US20130225692A1 (es)
EP (1) EP2635264B8 (es)
JP (1) JP5872573B2 (es)
KR (1) KR20130101102A (es)
CN (1) CN103384516B (es)
AR (1) AR083769A1 (es)
AU (1) AU2011324995B2 (es)
BE (1) BE1019493A3 (es)
BR (1) BR112013010884A2 (es)
CA (1) CA2816835A1 (es)
EA (1) EA024566B1 (es)
ES (1) ES2405531B1 (es)
IL (1) IL225892A0 (es)
MX (1) MX342181B (es)
MY (1) MY164204A (es)
NL (1) NL2007716C2 (es)
NZ (1) NZ611148A (es)
SG (1) SG190018A1 (es)
TW (1) TWI520730B (es)
WO (1) WO2012059724A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
WO2013119582A1 (en) * 2012-02-06 2013-08-15 University Of Utah Research Foundation Drug release from a polymer-controlled local antibiotic delivery system using a degradable bone graft
ES2909386T3 (es) 2012-09-11 2022-05-06 Norgine Bv Composiciones que comprenden polietilenglicol y sulfatos de metales alcalinos o alcalinotérreos para su uso como composiciones de limpieza de colon
EP2953581B1 (en) 2013-02-05 2020-09-16 University of Utah Research Foundation Implantable devices for bone or joint defects
RS59667B1 (sr) 2013-03-15 2020-01-31 Braintree Laboratories Inc Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
CA2947434A1 (en) 2014-04-29 2015-11-05 Colonaryconcepts Llc Foods, systems, methods, and kits for providing electrolyte replacement
AU2016315848A1 (en) * 2015-09-01 2018-04-12 Colonaryconcepts Llc Laxative formulations and manufacture
WO2017217049A1 (ja) 2016-06-15 2017-12-21 株式会社島津製作所 放射線撮影装置
FR3056109B1 (fr) * 2016-09-21 2019-10-11 Pierre Fabre Medicament Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation
CN112386577B (zh) * 2019-08-16 2024-01-23 北京天衡药物研究院有限公司 一种治疗便秘的组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710183A (en) * 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
WO2004075875A1 (en) * 2003-02-28 2004-09-10 Alk-Abello A/S Dosage form having a saccharide matrix
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
JP5276435B2 (ja) * 2005-05-06 2013-08-28 セイリックス ファーマシューティカルズ， インコーポレイティッド ポリエチレングリコールの結腸の下剤組成物
CO5790164A1 (es) * 2006-08-10 2007-08-31 Procaps S A Composicion farmaceutica solida que incluye en combinacion un agente regulador de la motilidad intestinal y un agente antiflatulento

Also Published As

Publication number Publication date
TWI520730B (zh) 2016-02-11
EP2635264B1 (en) 2018-05-30
US20160193245A1 (en) 2016-07-07
AU2011324995B2 (en) 2015-12-24
JP5872573B2 (ja) 2016-03-01
US20170296575A1 (en) 2017-10-19
BE1019493A3 (fr) 2012-07-03
SG190018A1 (en) 2013-06-28
AU2011324995A1 (en) 2013-05-02
ES2405531B1 (es) 2014-06-11
CA2816835A1 (en) 2012-05-10
EA201300539A1 (ru) 2013-09-30
JP2014500246A (ja) 2014-01-09
BR112013010884A2 (pt) 2016-08-02
ES2405531A2 (es) 2013-05-31
EP2635264B8 (en) 2018-07-18
US20130225692A1 (en) 2013-08-29
CN103384516B (zh) 2017-02-15
MX342181B (es) 2016-09-20
EP2635264A1 (en) 2013-09-11
TW201223522A (en) 2012-06-16
NL2007716C2 (en) 2012-11-13
MX2013004972A (es) 2013-08-27
KR20130101102A (ko) 2013-09-12
EA024566B1 (ru) 2016-09-30
NZ611148A (en) 2015-09-25
IL225892A0 (en) 2013-06-27
ES2405531R1 (es) 2013-06-07
WO2012059724A8 (en) 2013-06-06
WO2012059724A1 (en) 2012-05-10
MY164204A (en) 2017-11-30
NL2007716A (en) 2012-05-07
CN103384516A (zh) 2013-11-06

Similar Documents

Publication Publication Date Title
AR083769A1 (es) Formulaciones orales que comprenden polietilenglicol
MY161595A (en) Oral care compositions
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
MX369121B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral.
DOP2011000354A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
WO2013170068A3 (en) Nuclear transport modulators and uses thereof
DK201270677A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2012130820A3 (de) Isopentylester zur verwendung in kosmetischen, dermatologischen oder pharmazeutischen kompositionen
SG10201704712QA (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
MY163476A (en) Oral care compositions
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
CO6592109A2 (es) Nueva forma cristalina de un derivado de ciclopropilbenzamida
BR112014013327A2 (pt) composições para cuidado oral
IN2014DN10134A (es)
TN2013000172A1 (en) Formulations comprising polyethylene glycol
CR20150411A (es) Composiciones farmacéuticas que contienen dexketoprofeno y tramadol
ECSP15005163A (es) Composiciones líquidas orales pediátricas que contienen nepadutant
UA97076C2 (ru) Мазь противовоспалительная на основе сульфаниламида
UY35329A (es) Composición farmacéutica para administración oral que comprende fexofenadina y proceso para preparar la misma.
FR2993776B1 (fr) Agent actif et compositions cosmetiques anti-rides.
MX357329B (es) Extracto crudo de un hibrido de sechium edule, metodo para su extraccion y su uso para formulaciones con efecto antineoplasico.
CO6731123A2 (es) Composiciones de cuidado oral
MX2012007498A (es) Dentrifico libre de fluoruro y libre de agente tensioactivo anionico que tienen una elevada micro eficacia.
ZA201404201B (en) Oral care or cleanser composition comprising solubilized magnolol analogs and ppg-1-peg-9 lauryl glycol ether
UA97805U (uk) Лікарський засіб седативної дії у формі м'яких жувальних капсул

Legal Events

Date Code Title Description
FB Suspension of granting procedure